# Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma

> **NCT06461182** · PHASE2 · RECRUITING · sponsor: **Koo Foundation Sun Yat-Sen Cancer Center** · enrollment: 15 (estimated)

## Conditions studied

- Indolent B-Cell Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** Ga-68-CXCR4

## Key facts

- **NCT ID:** NCT06461182
- **Lead sponsor:** Koo Foundation Sun Yat-Sen Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-29
- **Primary completion:** 2026-04
- **Final completion:** 2027-04
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06461182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06461182, "Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06461182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*